Experienced in Spasmodic Dysphonia

Didier Dequanter

Department Of Otorhinolaryngology And Head And Neck Surgery, 
Brussels, BRU, BE 
Experienced in Spasmodic Dysphonia
Department Of Otorhinolaryngology And Head And Neck Surgery, 
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Didier Dequanter practices in Brussels, Belgium. Mr. Dequanter is rated as an Experienced expert by MediFind in the treatment of Spasmodic Dysphonia. His top areas of expertise are Laryngitis, Gastroesophageal Reflux Disease (GERD), Head and Neck Squamous Cell Carcinoma (HNSCC), Thyroidectomy, and Gastrostomy.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Spasmodic Dysphonia.

Gender
Male

Locations

Department Of Otorhinolaryngology And Head And Neck Surgery, Brussels, BRU, Belgium
Other Locations
Mons, WAL, Belgium
Department Of Head And Neck Surgery, 322, Rue Haute Brussels, Houte, VLG, Belgium
Charleroi, WAL, Belgium
Leuven, VLG, Belgium
Department Of Head And Neck Surgery, Rue De Gozée, 706, Montigny Le Tilleul, Gozee, WAL 6110, Belgium
Department Of Head And Neck Surgery, Belgium
Gosselies, WAL, Belgium
Rue De Gozée, 601, Le Tilleul, WAL 6110, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Pilot Study of Personalized Biomarker-based Treatment Strategy or Immunotherapy in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
A Pilot Study of Personalized Biomarker-based Treatment Strategy or Immunotherapy in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Enrollment Status: Active_not_recruiting
Publish Date: November 03, 2023
Intervention Type: Drug
Study Drugs: Afatinib, Palbociclib, Monalizumab, Durvalumab, Niraparib, Rogaratinib
Study Phase: Phase 2

99 Total Publications

Very Late-Onset Lingual Necrosis Post-radiation in an Adult: A Case Report.
Very Late-Onset Lingual Necrosis Post-radiation in an Adult: A Case Report.
Journal: Cureus
Published: August 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dequanter's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile